Clinical trials in Hoogeveen

22 clinical trials in Hoogeveen, The Netherlands. Every trial is listed in the EU Clinical Trials Register and updated daily.

Our site in the NetherlandsKlinischOnderzoek.nl

Hoogeveen at a glance

clinical trials

Paediatric trials0
Research sites0

Quick filters

22 trials in Hoogeveen

Open in trial search

Cardiovascular disorder+1

Recruiting

Study of Zilebesiran Added to Standard Treatment to Reduce Heart Problems in Adults with High Blood Pressure and Heart Disease Risk

Investigational

Study of Zilebesiran Added to Standard Treatment to Reduce Heart Problems in Adults with High Blood Pressure and Heart Disease Risk

Investigational

The Netherlands

Participants:18–64 years · 65+ years
Substances:Zilebesiran
Sponsor:Alnylam Pharmaceuticals Inc.

Contact Research Centre

Cardiovascular disorder+2

Recruiting

Study of vicadrostat and empagliflozin combination in patients with type 2 diabetes, high blood pressure and cardiovascular disease

Registered drug

Study of vicadrostat and empagliflozin combination in patients with type 2 diabetes, high blood pressure and cardiovascular disease

Registered drug

The Netherlands

Participants:18–64 years · 65+ years
Substances:BI 690517
Sponsor:Boehringer Ingelheim Espana S.A.

Contact Research Centre

Study on Baxdrostat and Dapagliflozin for Preventing Heart Failure in Patients at High Risk

Recruiting

Registered drug

Study on Baxdrostat and Dapagliflozin for Preventing Heart Failure in Patients at High Risk

Registered drug

The Netherlands

Participants:18–64 years · 65+ years
Substances:Baxdrostat
Sponsor:AstraZeneca AB

Contact Research Centre

Prolymphocytic leukaemia+2

Recruiting

Study on the Effectiveness of Entrectinib and Other Drug Combinations for Patients with Advanced Solid Tumors, Multiple Myeloma, or Non-Hodgkin Lymphoma

Registered drugNo placebo

Study on the Effectiveness of Entrectinib and Other Drug Combinations for Patients with Advanced Solid Tumors, Multiple Myeloma, or Non-Hodgkin Lymphoma

Registered drugNo placebo

The Netherlands

Participants:18–64 years · 65+ years
Substances:Abemaciclib
Sponsor:Het Nederlands Kanker Instituut-Antoni van Leeuwenhoek Ziekenhuis Stichting

Contact Research Centre

Arteriosclerosis

Not yet recruiting

A study to evaluate the effect of muvalaplin on reducing major cardiovascular events in adults with high levels of lipoprotein(a) and atherosclerotic cardiovascular disease.

Investigational

A study to evaluate the effect of muvalaplin on reducing major cardiovascular events in adults with high levels of lipoprotein(a) and atherosclerotic cardiovascular disease.

Investigational

The Netherlands

Participants:18–64 years · 65+ years
Sponsor:Eli Lilly & Co.

Contact Research Centre

Arteriosclerosis

Not recruiting

Study of maridebart cafraglutide to reduce cardiovascular problems in overweight or obese patients with atherosclerotic cardiovascular disease

Investigational

Study of maridebart cafraglutide to reduce cardiovascular problems in overweight or obese patients with atherosclerotic cardiovascular disease

Investigational

The Netherlands

Participants:18–64 years · 65+ years
Substances:Maridebart Cafraglutide
Sponsor:Amgen Inc.

Contact Research Centre

Familial hypertriglyceridaemia+1

Not recruiting

Study of ISIS 678354 for Patients with Severe High Triglycerides

Investigational

Study of ISIS 678354 for Patients with Severe High Triglycerides

Investigational

The Netherlands

Participants:18–64 years · 65+ years
Substances:ISIS 678354 sodium salt
Sponsor:Ionis Pharmaceuticals Inc.

Contact Research Centre

Dyslipidaemia

Not recruiting

Study of Evolocumab to Prevent Heart Disease Events in High-Risk Patients Without Previous Heart Attack or Stroke

Registered drug

Study of Evolocumab to Prevent Heart Disease Events in High-Risk Patients Without Previous Heart Attack or Stroke

Registered drug

The Netherlands

Participants:18–64 years · 65+ years
Substances:Evolocumab
Sponsor:Amgen Inc.

Contact Research Centre

Hypertriglyceridaemia+1

Not recruiting

Study of Olezarsen (ISIS 678354) for Patients with High Triglycerides and Heart Disease or Severe High Triglycerides

Investigational

Study of Olezarsen (ISIS 678354) for Patients with High Triglycerides and Heart Disease or Severe High Triglycerides

Investigational

The Netherlands

Participants:18–64 years · 65+ years
Substances:ISIS 678354 sodium salt
Sponsor:Ionis Pharmaceuticals Inc.

Contact Research Centre

Hypertriglyceridaemia

Not recruiting

Study of ISIS 678354 for Patients with Severe Hypertriglyceridemia

InvestigationalNo placebo

Study of ISIS 678354 for Patients with Severe Hypertriglyceridemia

InvestigationalNo placebo

The Netherlands

Participants:18–64 years · 65+ years
Substances:ISIS 678354 sodium salt
Sponsor:Ionis Pharmaceuticals Inc.

Contact Research Centre

Type 2 diabetes mellitus

Not recruiting

Evaluation of Tirzepatide Versus Dulaglutide on Major Adverse Cardiovascular Events in Type 2 Diabetes Patients with High Cardiovascular Risk

Registered drugNo placebo

Evaluation of Tirzepatide Versus Dulaglutide on Major Adverse Cardiovascular Events in Type 2 Diabetes Patients with High Cardiovascular Risk

Registered drugNo placebo

The Netherlands

Participants:18–64 years · 65+ years
Substances:Dulaglutide
Sponsor:Eli Lilly & Co.

Contact Research Centre

Obesity

Not recruiting

Weight loss in adults with obesity (with or without type 2 diabetes) using cagrilintide and semaglutide: a study of two dose levels versus semaglutide alone

InvestigationalNo placebo

Weight loss in adults with obesity (with or without type 2 diabetes) using cagrilintide and semaglutide: a study of two dose levels versus semaglutide alone

InvestigationalNo placebo

The Netherlands

Participants:18–64 years · 65+ years
Substances:Cagrilintide
Sponsor:Novo Nordisk A/S

Contact Research Centre

Other cities in the Netherlands

The busiest research cities in the country

All 103 cities in the Netherlands

Clinical research in Hoogeveen

What the registry says about research in the country

01 Cardiovascular Research

Innovative trials focusing on heart failure prevention and atherosclerotic cardiovascular disease management, evaluating new therapeutic approaches for reducing major cardiac events.

Heart Failure Prevention Studies
Cardiovascular Risk Management
Atherosclerosis Treatment

Research includes combination therapy evaluations and novel drug investigations for high-risk cardiac patients.

02 Metabolic Disorders

Comprehensive studies addressing obesity and various types of diabetes mellitus, including investigations into weight management therapies and blood sugar control.

Type 1 Diabetes Treatments
Type 2 Diabetes Management
Gestational Diabetes Research

Studies explore innovative medications combined with lifestyle interventions for optimal patient outcomes.

03 Oncology Studies

Advanced research in solid tumors and blood cancers, with specialized focus on targeted therapies for non-Hodgkin lymphoma and multiple myeloma.

Esophagogastric Cancer Treatments
Blood Cancer Therapies
Targeted Cancer Medications

Trials evaluate personalized treatment approaches based on genomic and protein expression variants.

04 Lipid Disorders

Specialized research focusing on severe hypertriglyceridemia and related cardiovascular complications, testing new therapeutic approaches.

Triglyceride Level Management
Cardiovascular Risk Reduction
Novel Lipid-Lowering Therapies

Studies aim to evaluate safety and efficacy of new treatments for various forms of lipid disorders.

Back to the Netherlands All countries